News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline
Monday, October 14, 2024Akeso Biopharma announced that it has successfully raised approximately million USD through a share placement This offering has earned notable recognition among international investment firms with the majority of our final subscribers being longterm...
Bayer submits application for third indication of darolutamide in the EU
Monday, October 14, 2024Bayer today announced the submission of an application to the European Medicines Agency EMA for the oral androgen receptor inhibitor ARi darolutamide Bayer is seeking approval for the use of darolutamide in combination with androgen deprivation thera...
Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline
Monday, October 14, 2024H Lundbeck AS and Longboard Pharmaceuticals Inc today announced an agreement for Lundbeck to acquire Longboard Under the terms of the agreement Lundbeck will commence a tender offer for all outstanding shares of Longboard common stock whereby Longboa...
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
Friday, October 11, 2024Clearmind Medicine Inc a clinicalstage biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems today announced it has received Institutional Review Board
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
Thursday, October 10, 2024Pharming Group NV announces the start of a Phase II proof of concept clinical trial evaluating leniolisib in primary immunodeficiencies PIDs with immune dysregulation linked to altered PIK signaling in lymphocytes The clinical trial is open for enrol...
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
Wednesday, October 09, 2024Tonix Pharmaceuticals Holding Corp a fullyintegrated biopharmaceutical company with marketed products and a pipeline of development candidates today announced that it has entered into an AI and ML research collaboration with XChem Inc XChem a leader...
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
Wednesday, October 09, 2024Oragenics Inc a company focused on developing new treatments for brainrelated health conditions has completed a key study for their new concussion drug ONP This drug is designed to be delivered through the nose which could help it reach the brain qui...
NMDP BioTherapies℠ Relaunches Premium Services Supporting Autologous Cell Therapies
Tuesday, October 08, 2024NMDP BioTherapies formerly known as the Be The Match BioTherapies a leader in cell and gene therapy development support announced today it is relaunching an improved suite of premium services for developers of autologous cell and gene therapies in re...
Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries
Tuesday, October 08, 2024Orchard Therapeutics recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe and ErKim an international pharmaceutical company specializing in the commercialization of novel thera...
IMU Biosciences joins ground-breaking UK research consortium investigating patient response to cancer immunotherapies
Monday, October 07, 2024IMU Biosciences a biotechnology company pioneering systemslevel immune profiling with AI to drive breakthroughs in precision medicine is pleased to announce its participation in MANIFEST Multiomic ANalysis of Immunotherapy Features Evidencing Success...
